New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

CSL has received approval from the EC for Andembry (garadacimab) to prevent recurrent attacks of HAE in patients aged 12 ...

As regulations take shape around sustainable product design, Avnet’s Stacy Mendez highlights the laws that could have an ...

The Money and Mental Health Policy Institute, established by Martin Lewis, has announced the formation of the Gambling Harms ...

From February 2021 to September 2023, consumers reported almost 3,500 cases of alleged IBAN discrimination on the 'Accept My ...

The new 'Travel Rule' mandates crypto exchanges to share client information when facilitating crypto transfers above R5 000 ...

To effectively harness AI's potential, companies can adopt strategic approaches that facilitate AI adoption within their ...

A daily download of the topics driving the tech policy agenda, from Brussels to London to Silicon Valley. By TOM BRISTOW with ...

Trump has said that the government should raise more of its revenues from tariffs, as it did before the income tax became ...

The European Union can negotiate on reciprocal tariffs with the United States but will not give up its right to regulate in ...

On February 11, 2025, the European Commission made available its 2025 work program (the “Work Program”). The Work Program ...

NBFCs urge RBI to raise the ECB limit, ease SARFAESI norms for small loans, expedite eKYC approvals, and relax asset ...